DermTech, LLC
PrivateLast Round
Follow-on Offering
Jan 11, 2021
Est. Valuation
$713.1M
Total Funding Raised
$235.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DermTech, LLC is a precision dermatology company that develops and markets non-invasive skin genomics solutions to facilitate the assessment of skin cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DermTech, LLC Comparables
Compare DermTech, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Castle Biosciences, Inc. | 74% | |
| SkylineDx | 73% | |
| Scibase Holding | 73% |
DermTech, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jan 11, 2021 | ||||
| PIPE | Mar 4, 2020 | ||||
| Reverse Merger | Aug 29, 2019 | ||||
| Series C | Feb 7, 2018 | ||||
| Series B Extension | Apr 15, 2015 | ||||
Series B | Aug 14, 2013 |
DermTech, LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jacobs Investment Company, LLC | Series A |
| HLM Investment Partners | Reverse Merger |
| Oppenheimer & Co. Inc. | Follow-on Offering |
| William Blair & Company | Follow-on Offering |
| BTIG | Follow-on Offering |
| RTW Investments | Reverse Merger, Series C |
| Craig-Hallum Capital Group | Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 87% MoM, from 1.6K to 3K.
- Mar 27, 2025
Monthly visitors increased 121% MoM, reaching 7.5K.
DermTech, LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access